Exhibit 107

Calculation of Filing Fee Tables

FORM S-3

(Form Type)

Dianthus Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry  Forward  Form Type

Carry  Forward  File Number

Carry  Forward  Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Equity

Common stock, par value $0.001 per share(1)

Rule 457 (c)

5,464,001(2)

$13.40(3)

$73,217,613.40(3)

0.00014760

$10,806.92

Fees Previously Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Carry Forward Securities

Carry Forward Securities

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Total Offering Amounts

$73,217,613.40

$10,806.92

Total Fees Previously Paid

—

Total Fee Offsets

—

Net Fee Due

$10,806.92

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers such an indeterminate amount of shares of common stock of the registrant as may become issuable to prevent dilution resulting from stock splits, stock dividends and similar events.

(2) The amount registered consists of (i) 5,253,681 shares of common stock of the registrant held by the selling stockholders and (ii) 210,320 shares of common stock of the registrant issuable upon the exercise of 210,320 pre-funded warrants of the registrant held by certain selling stockholders.

(3) Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock of the registrant on The Nasdaq Capital Market on October 2, 2023 (such date being within five business days of the date that this registration statement was first filed with the U.S. Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act).